Marknadens största urval
Snabb leverans

Pharma M&A versus alliances and its underlying value drivers

- Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

Om Pharma M&A versus alliances and its underlying value drivers

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

Visa mer
  • Språk:
  • Engelska
  • ISBN:
  • 9783631663813
  • Format:
  • Inbunden
  • Sidor:
  • 201
  • Utgiven:
  • 28. september 2015
  • Utgåva:
  • Mått:
  • 215x154x17 mm.
  • Vikt:
  • 362 g.
  Fri leverans
Leveranstid: 2-4 veckor
Förväntad leverans: 18. december 2024

Beskrivning av Pharma M&A versus alliances and its underlying value drivers

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

Användarnas betyg av Pharma M&A versus alliances and its underlying value drivers



Hitta liknande böcker
Boken Pharma M&A versus alliances and its underlying value drivers finns i följande kategorier:

Gör som tusentals andra bokälskare

Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.